Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL EBITDA Margin
EBITDA as a percentage of revenue.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -3569.4%
EBITDA Margin was -3569.4% in Q1 FY2026, down 2689.8 pp from a year earlier. On a trailing-twelve-month basis it was -10.7%, up 104.7 pp year over year. Over 3 fiscal years it widened by 365.5 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 1 analysts of -2101.6% for the fiscal year ending Dec 2026, down from -38.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -3569.4%-3079.4 pp QoQ
- Last fiscal yearDec 2025
- -38.3%+51.4 pp YoY
- LTMMar 2026
- -10.7%+104.7 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -38.3%
- Year-over-year change
- +51.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -38.3% | +51.4pp |
| FY2024 | 2024-12-31 | -89.7% | +1774.1pp |
| FY2023 | 2023-12-31 | -1863.8% | -1459.9pp |
| FY2022 | 2022-12-31 | -403.9% | -416.2pp |
| FY2021 | 2021-12-31 | 12.3% | — |
EBITDA Margin vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's LTM Mar 2026 EBITDA Margin of -10.7% is the 2nd highest of the 6 companies compared; the peer median is -265.8%.
- Its year-over-year change of +104.7 pp is the 3rd highest of 5, against a peer median of +108.4 pp.
- Over three fiscal years its change of +365.5 pp compares with a peer median of +1700.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | 3772.2% | — | +5140.2 pp | |
| LTM Mar 2026 | -10.7% | +104.7 pp | +365.5 pp | |
| LTM Mar 2026 | -32.2% | -1.2 pp | +32.0 pp | |
| LTM Mar 2026 | -265.8% | +218.0 pp | — | |
| LTM Mar 2026 | -337.0% | +4411.9 pp | +3368.5 pp | |
| LTM Mar 2026 | -21792.5% | -14931.4 pp | -5585.1 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding SLGL) | -265.8% | +108.4 pp | +1700.3 pp | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 31.27M | 3.88M | 1.55M | 11.54M | 19.39M |
| Cost of Revenue | 20.38M | 12.68M | 342K | 233K | 109K |
| Gross Profit | 10.89M | (8.8M) | (21.99M) | 11.31M | 19.39M |
| Gross Margin | 34.8% | -226.6% | -1414.9% | 98.0% | 100.0% |
| Research & Development | 20.38M | 12.68M | 23.54M | 17.8M | 22.8M |
| Selling, General & Admin | 8.45M | 7.45M | 7.37M | 5.75M | 4.18M |
| Operating Expenses | 7.93M | 7.45M | 7.32M | 23.32M | 26.93M |
| Depreciation & Amortization | 880K | 562K | 342K | 233K | 109K |
| EBITDA | 3.84M | (15.68M) | (28.96M) | (10.35M) | (7.43M) |
| EBITDA Margin | 12.3% | -403.9% | -1863.8% | -89.7% | -38.3% |
| Operating Income | 2.96M | (16.24M) | (29.31M) | (12.01M) | (7.54M) |
| Operating Margin | 9.5% | -418.3% | -1885.8% | -104.1% | -38.9% |
| Interest Income | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Income Before Tax | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Pre-Tax Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Net Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| EPS (Basic) | 1.40 | (0.65) | (1.01) | (0.38) | (2.20) |
| EPS (Diluted) | 0.14 | (0.65) | (1.01) | (0.38) | (2.20) |
| Weighted Avg Shares | 23.06M | 23.13M | 27.09M | 27.86M | 2.79M |
| Weighted Avg Shares (Diluted) | 23.57M | 23.13M | 27.09M | 27.86M | 2.79M |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.